We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil Details Requirements for National Drug Tracking System
Brazil Details Requirements for National Drug Tracking System
Drugmakers operating in Brazil must report all supply chain movements to Anvisa in real time, according to new guidance on the agency’s drug tracking and tracing system. While the system has broad industry support, an attorney familiar with it says it doesn’t address concerns with biosimilars.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor